Skip to main content

Table 2 % distribution of different groups of comorbidities in the whole sample and by gender

From: Prevalence of different comorbidities in COPD patients by gender and GOLD stage

Comorbidities Overall
%
(n = 3,198)
Males
%
(n = 2,182)
Females
%
(n = 1,016)
Cardio-Vascular 39.0 44.7 30.7
Respiratory 22.4 23.0 21.1
Metabolic 10.4 9.2 12.4
Oncologic 7.6 7.0 8.5
Neuro Psychiatric 6.5 6.6 6.2
Gastro Enterologic 8.6 4.8 14.2
Osteo-Articular 4.9 3.8 6.0
Other 0.6 0.9 0.9